Slovene Pharmaceutical Company Lek to Enter London Stock Exchange
Ljubljana, 3 July - The shareholders assembly representing 58.42 percent of Slovene pharmaceutical company Lek's stock took a decision on Tuesday not to divide the 2000 profit at SIT 5.36 billion (24.7 million euros). The company, however will ensure almost SIT two billion (9.2 million euros) for dividends, said Chairman of the Board Metod Dragonja.
The rest of this news item is available to subscribers.
The news item consists of 483 characters (without spaces) or 97 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.